Two Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Studies To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza A Virus Monoclonal Antibody, MHAA4549A, in Healthy Volunteers (Q37203832)
Jump to navigation
Jump to search
scientific article published on 05 July 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Two Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Studies To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza A Virus Monoclonal Antibody, MHAA4549A, in Healthy Volunteers |
scientific article published on 05 July 2016 |
Statements
1 reference
Two Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Studies To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza A Virus Monoclonal Antibody, MHAA4549A, in Healthy Volunteers (English)
1 reference
Influenza A Virus
1 reference
Mauricio Maia
1 reference
Jeremy J Lim
1 reference
Rong Deng
1 reference
Michael A Derby
1 reference
Richard Larouche
1 reference
Priscilla Horn
1 reference
Malia Anderson
1 reference
Stephanie Carrier
1 reference
Isabelle Pelletier
1 reference
Tracy Burgess
1 reference
Priya Kulkarni
1 reference
Elizabeth Newton
1 reference
Jorge A Tavel
1 reference
1 reference
1 reference
Identifiers
1 reference